APA (7th ed.) Citation

Merz, M., Bertsch, U., Mai, E. K., Hose, D., Schurich, B., & Goldschmidt, H. (2014). Subcutaneous versus intravenous bortezomib in two different induction therapies for fewly diagnosed multiple myeloma: Elektronische Ressource$dsubgroup analysis from the GMMG-MM5 trial. Blood, 124(21), .

Chicago Style (17th ed.) Citation

Merz, Maximilian, Uta Bertsch, Elias K. Mai, Dirk Hose, Bärbel Schurich, and Hartmut Goldschmidt. "Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Fewly Diagnosed Multiple Myeloma: Elektronische Ressource$dsubgroup Analysis from the GMMG-MM5 Trial." Blood 124, no. 21 (2014).

MLA (9th ed.) Citation

Merz, Maximilian, et al. "Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Fewly Diagnosed Multiple Myeloma: Elektronische Ressource$dsubgroup Analysis from the GMMG-MM5 Trial." Blood, vol. 124, no. 21, 2014.